Treace Medical Concepts Inc expected to post a loss of 12 cents a share - Earnings Preview

Treace Medical Concepts

03/11/2021 13:33

* Treace Medical Concepts Inc  TMCI.OQ   TMCI.O  is expected
to report results on November 4.
* The Ponte Vedra, Florida-based company is expected to report
revenue of $21 million, according to the mean estimate from 3
analysts, based on Refinitiv data.  
​* Refinitiv's mean analyst estimate for Treace Medical Concepts
Inc is for a loss of 12 cents per share. 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 3 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
* The mean earnings estimate of analysts was unchanged in the
last three months. ​
* Wall Street's median 12-month price target for Treace Medical
Concepts Inc is $37​, about 37.4% above​ its last closing price
of $23.16. ​​​
* Previous quarterly performance (using preferred earnings
measure in US dollars). ​
 QUARTER       STARMINE    REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        SMARTESTIM  IBES                 MET,    SE %
               ATE®        ESTIMATE             MISSED  
 Jun. 30 2021  -0.12       -0.12      -0.10     Beat    16.7
 Mar. 31 2021  -0.06       -0.06      -0.07     Missed  -16.7
                                                        ​
 ​​                                                     
                                                        ​
 This summary was machine generated November 3 at 13:33 GMT.  All
figures in US dollars unless otherwise stated